C4 Therapeutics, Inc. · NASDAQ:CCCC

Morgan Stanley reported a 9.30% stake in C4 Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 11, 2026

Morgan Stanley reported a 9.30% stake in C4 Therapeutics, Inc., 8,974,191 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).

Stake
9.30%
Shares
8,974,191
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Morgan Stanley9.30%8,974,191
Morgan Stanley & Co. LLC9.20%8,897,942

Source

View original at SEC

Related